We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

February 26, 2021

“These are interventions that actually work” Brian Dolan

Reports
Ian Matthews
&

This month’s Digital Health Videocast sees us sit down with Brian Dolan, Founder and lead writer of Exits & Outcomes (E&O), following the highly successful launch of our latest industry report Prescription Digital Therapeutics (PDT) The Future of Digital Therapeuticsco-created by HealthXL and E&O.


For those of you following our videocast series, there may be a sense of déjà vu as we learn of Brian’s early career connection with Washington DC (much like our previous sit-downs with Sarah Iselin, Chris Coburn and Steve Kraus). Having attended Boston University and taking advantage of their excellent journalism school Brian was to find himself placed in Washington DC as a political correspondent for a semester. A career as a political journalist was not on the cards but Washington had captivated him. On graduating from Boston University Brian moved to the nation’s capital permanently as an editor for the media brand Fierce Markets. It was during his tenure here in which he was exposed to both technology and healthcare publications, helping to launch a series of publications focused on mobile in the mid-2000s. 


We learn of his passion as he watched the mobile industry evolve out of nothing, indeed an industry that would be paramount to the evolution of healthcare. On seeing mobile solutions being adopted across industries Brian felt there was ample opportunity to integrate it with the healthcare industry who had not fully embraced it yet and so in 2008 MobiHealthNews was born as a health tech publication.


Brian’s understanding of the fusion and possibilities between technology and healthcare has evolved over the past decade as the industry moved from the early days of med-tech to what we know now as digital health. 


Digital health has come to mean so many things” Brian tells us and it is perhaps for this reason he founded Exits & Outcomes in 2019. “Digital health has matured considerably in the past 12 years since I first started writing about it, but most health tech journalism is still written for those just entering the discussion. Exits & Outcomes (E&O) is a subscription-only, weekly newsletter for digital health strategists, creatives, and operators.”


It is Brian's experience in this industry that makes him such a valuable collaborator on our latest industry report. HealthXL released our first industry report on Digital Therapeutics (DTx) back in 2018 but so much has changed since then. A wide variety of companies have co-opted the term “digital therapeutics'' to describe their digital health offerings. We discuss our collaboration on the report which seeks to cut through some of that noise by focusing on a smaller promising subset of this group: prescription digital therapeutics.


A key part of our conversation turns to how we may define DTx with Brian summing up “The key to it is (DTx) are not just interventions but they have some sort of evidence to back them up...These are interventions that actually work”.


During the videocast we dive into a number of areas including:


What does the future of DTx look like to you. ? Get in touch with us here!

HealthXL Executive members can access the report for free on the Community Hub. If you are not an Executive member yet, you can access an 11-page snapshot for free here.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Sustainable Business Models for DTx

16th August @ 10:45AM EDT

It is one of the key questions that every digital therapeutic (DTx) company must answer - what business model will set them up for success in the long run? Join this meeting to discuss this further and share your experiences with your peers working in this space.

Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Payers Partnerships for DTx

17th August @ 10:45AM EDT

Digital Therapeutics (DTx) vendors face many challenges on their journey to commercialization, such as generating clinical data, health economics evidence and achieving regulatory status. Join this meeting to discuss this topic further and share your experiences with others working in this space.

Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Kevin Darcy
Kevin Darcy
Director, Link Strategy at Veeva Systems
Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Kevin Darcy
Kevin Darcy
Director, Link Strategy at Veeva Systems
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Sprint: How to Overcome the Blockers to DTx Adoption and Measure Success? (Part 2)

25th August @ 10:45AM EDT

While new legislations and rules (such as DiGA in Germany) have opened new options for reimbursement, adoption of digital therapeutics (DTx) remains insufficient to achieve the revenue expected from these solutions. Join this 2 part sprint to discuss this topic further.

Featuring
Mette Dyhrberg
Mette Dyhrberg
Founder & CEO, Mymee
Richard DeNunzio
Richard DeNunzio
SVP, Commercial at Click Therapeutics, Inc.
Featuring
Mette Dyhrberg
Mette Dyhrberg
Founder & CEO, Mymee
Richard DeNunzio
Richard DeNunzio
SVP, Commercial at Click Therapeutics, Inc.
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: DTx Reimbursement in the US: Government-sponsored plans (Medicaid and Medicare)

30th August @ 10:45AM EDT

Are you a digital therapeutics (DTx) company seeking reimbursement in the US market? Join this masterclass led by the biopharma and DTx reimbursement expert Mike Pace to dive deeper into this topic.

Featuring
Michael Pace
Michael Pace
CEO & Founder at PalmHealth.co
Featuring
Michael Pace
Michael Pace
CEO & Founder at PalmHealth.co

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Executive 1-2-1 with the HealthXL Digital Health Community

15th August @11AM EDT

Do you want to network with other innovators and leaders in digital health? Are you looking to identify potential partners? Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!

Featuring
Aahuti Rai
Aahuti Rai
Strategic Advisor, Healthcare Innovation at Four Points Consulting Ltd
Chris Wasden
Chris Wasden
Head of Pharma Speciality Solutions & Corporate Strategy, Twill
Featuring
Aahuti Rai
Aahuti Rai
Strategic Advisor, Healthcare Innovation at Four Points Consulting Ltd
Chris Wasden
Chris Wasden
Head of Pharma Speciality Solutions & Corporate Strategy, Twill
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Sustainable Business Models for DTx

16th August @ 10:45AM EDT

It is one of the key questions that every digital therapeutic (DTx) company must answer - what business model will set them up for success in the long run? Join this meeting to discuss this further and share your experiences with your peers working in this space.

Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Payers Partnerships for DTx

17th August @ 10:45AM EDT

Digital Therapeutics (DTx) vendors face many challenges on their journey to commercialization, such as generating clinical data, health economics evidence and achieving regulatory status. Join this meeting to discuss this topic further and share your experiences with others working in this space.

Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Kevin Darcy
Kevin Darcy
Director, Link Strategy at Veeva Systems
Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Kevin Darcy
Kevin Darcy
Director, Link Strategy at Veeva Systems
Digital Health in Oncology
Digital Health in Oncology
Digital Health in Oncology
Digital Health in Oncology

Incentive Models for HCP & Care Team to Adopt Digital Health in Oncology

23rd August @ 10:45AM EDT

What are the best incentive models to encourage health care professionals (HCPs) and care teams to adopt digital health in oncology? Join this meeting to discuss this topic further with others working in this space.

Featuring
Susan Bratton
Susan Bratton
CEO & Founder at Savor Health
Ary Deleray
Ary Deleray
Personalized & Digital Health Strategy at Roche
Featuring
Susan Bratton
Susan Bratton
CEO & Founder at Savor Health
Ary Deleray
Ary Deleray
Personalized & Digital Health Strategy at Roche

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.